Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
VRCA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $71.12M
- EPS (TTM)
- -$1.71
- Dividend yield
- None
- 52-week range
- 3.28 – 9.82
- Day range
- 4.06 – 4.33
- Volume / Avg
- 47.55K / 62.77K
- Beta
- —
- Shares outstanding
- 17.18M
52-week range
VRCA stock today
On Oct 7, VRCA ended the session at $4.14, shedding $0.07 (1.66%), versus the S&P 500's 0.22% decline. At this level, VRCA sits near the bottom of its 52-week range of $3.28 to $9.82: 57.8% below the high, set on Nov 28, 2025 and 26.2% above the low. VRCA is down 50.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 10.2%.
Verrica Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$1.71), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Verrica Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2018
Verrica Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OSTXOS Therapies Incorporated | 1.55 | +4.03% | $72.55M | vs VRCA |
| MAIAMAIA Biotechnology Inc. | 1.18 | -0.84% | $72.86M | vs VRCA |
| GANXGain Therapeutics Inc. | 1.67 | 0.00% | $72.88M | vs VRCA |
| HRTXHeron Therapeutics Inc. | 0.3843 | +15.86% | $72.96M | vs VRCA |
| TENXTenax Therapeutics Inc. | 1.91 | -1.04% | $71.48M | vs VRCA |
| CINGCingulate Inc. | 4.87 | -0.41% | $70.82M | vs VRCA |
| HYFTMindWalk Holdings Corp. | 1.50 | -3.23% | $70.67M | vs VRCA |
| LFVNLifevantage Corporation | 6.00 | -0.66% | $75.54M | vs VRCA |
Indexes, lists and sector
Verrica Pharmaceuticals stock FAQ
What is Verrica Pharmaceuticals's stock price today?
VRCA last traded at $4.14 as of Oct 7, 4:00 PM EDT, down 1.66% on the day. Prices are delayed at least 15 minutes.
Does Verrica Pharmaceuticals pay a dividend?
No. Verrica Pharmaceuticals does not currently pay a regular cash dividend.
Has VRCA ever split its stock?
Yes. The most recent VRCA stock split was a 1-for-10 split on Jul 25, 2025.
What is the VRCA 52-week high?
The 52-week high for VRCA is $9.82 and the 52-week low is $3.28. The stock is currently 57.8% below its high.